17-39408088-G-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2

The NM_004774.4(MED1):​c.4133C>A​(p.Thr1378Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000342 in 1,461,830 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

MED1
NM_004774.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.79
Variant links:
Genes affected
MED1 (HGNC:9234): (mediator complex subunit 1) The activation of gene transcription is a multistep process that is triggered by factors that recognize transcriptional enhancer sites in DNA. These factors work with co-activators to direct transcriptional initiation by the RNA polymerase II apparatus. The protein encoded by this gene is a subunit of the CRSP (cofactor required for SP1 activation) complex, which, along with TFIID, is required for efficient activation by SP1. This protein is also a component of other multisubunit complexes e.g. thyroid hormone receptor-(TR-) associated proteins which interact with TR and facilitate TR function on DNA templates in conjunction with initiation factors and cofactors. It also regulates p53-dependent apoptosis and it is essential for adipogenesis. This protein is known to have the ability to self-oligomerize. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11419833).
BS2
High AC in GnomAdExome4 at 5 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MED1NM_004774.4 linkuse as main transcriptc.4133C>A p.Thr1378Asn missense_variant 17/17 ENST00000300651.11 NP_004765.2 Q15648-1
MED1XM_047436314.1 linkuse as main transcriptc.3617C>A p.Thr1206Asn missense_variant 13/13 XP_047292270.1
MED1XM_047436315.1 linkuse as main transcriptc.3476C>A p.Thr1159Asn missense_variant 9/9 XP_047292271.1
MED1XM_006721957.3 linkuse as main transcriptc.1640+2493C>A intron_variant XP_006722020.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MED1ENST00000300651.11 linkuse as main transcriptc.4133C>A p.Thr1378Asn missense_variant 17/171 NM_004774.4 ENSP00000300651.6 Q15648-1
MED1ENST00000394287.7 linkuse as main transcriptc.1640+2493C>A intron_variant 1 ENSP00000377828.3 Q15648-3
MED1ENST00000577831.5 linkuse as main transcriptn.*3706C>A non_coding_transcript_exon_variant 16/162 ENSP00000463307.1 J3QKZ7
MED1ENST00000577831.5 linkuse as main transcriptn.*3706C>A 3_prime_UTR_variant 16/162 ENSP00000463307.1 J3QKZ7

Frequencies

GnomAD3 genomes
Cov.:
31
GnomAD4 exome
AF:
0.00000342
AC:
5
AN:
1461830
Hom.:
0
Cov.:
35
AF XY:
0.00000550
AC XY:
4
AN XY:
727214
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000450
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
31
Bravo
AF:
0.00000378

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 14, 2024The c.4133C>A (p.T1378N) alteration is located in exon 17 (coding exon 17) of the MED1 gene. This alteration results from a C to A substitution at nucleotide position 4133, causing the threonine (T) at amino acid position 1378 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.072
BayesDel_addAF
Benign
-0.25
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
20
DANN
Benign
0.86
DEOGEN2
Benign
0.085
T
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.048
FATHMM_MKL
Uncertain
0.89
D
LIST_S2
Benign
0.69
T
M_CAP
Benign
0.0048
T
MetaRNN
Benign
0.11
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
-0.47
N
REVEL
Benign
0.013
Sift
Benign
0.17
T
Sift4G
Benign
0.46
T
Polyphen
0.0020
B
Vest4
0.14
MutPred
0.36
Loss of phosphorylation at T1378 (P = 0.0092);
MVP
0.19
MPC
0.31
ClinPred
0.12
T
GERP RS
4.6
Varity_R
0.048
gMVP
0.058

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2048320157; hg19: chr17-37564341; API